Friday, Aug 14, 2020 | Last Update : 03:06 PM IST

142nd Day Of Lockdown

Maharashtra54831338184318650 Tamil Nadu3145202563135278 Andhra Pradesh2641421709242378 Karnataka1964941126333511 Delhi1494601343184167 Uttar Pradesh140775887862280 West Bengal98459671202059 Telangana8647563074665 Bihar8274154139450 Gujarat71064542382652 Assam5883842326145 Rajasthan5249738235789 Odisha4592731785321 Haryana4163534781483 Madhya Pradesh3902529020996 Kerala3811424922127 Jammu and Kashmir2489717003472 Punjab2390315319586 Jharkhand185168998177 Chhatisgarh12148880996 Uttarakhand96326134125 Goa871259575 Tripura6161417641 Puducherry5382320187 Manipur3752204411 Himachal Pradesh3371218114 Nagaland30119738 Arunachal Pradesh223115923 Chandigarh1595100425 Meghalaya11154986 Sikkim9105101 Mizoram6203230
  Business   Companies  02 Jul 2020  Novartis reaches $678 million settlement with US authorities over doctor-bribe claims

Novartis reaches $678 million settlement with US authorities over doctor-bribe claims

PTI
Published : Jul 2, 2020, 12:22 pm IST
Updated : Jul 2, 2020, 12:22 pm IST

The settlement resolves a 2011 whistleblower lawsuit accusing Novartis of violating the federal False Claims Act and Anti-Kickback Statute

 Novartis Pharmaceutical Corp. will pay $678 million to the U.S. government to resolve suit over sham doctor outings. (PTI Photo)
  Novartis Pharmaceutical Corp. will pay $678 million to the U.S. government to resolve suit over sham doctor outings. (PTI Photo)

New York: Novartis Pharmaceutical Corp. will pay $678 million to the U.S. government and various states to settle a lawsuit over a sham speaker programme that distributed cash, expensive dinners and other treats to induce doctors to prescribe its products, federal authorities announced Wednesday.

The settlement of the lawsuit was announced by Acting Manhattan U.S. Attorney Audrey Strauss, who said the company splurged on “speaking fees, exorbitant meals, and top-shelf alcohol that were nothing more than bribes to get doctors across the country to prescribe Novartis's drugs.”

 

Messages seeking comment were left with lawyers for Novartis Pharmaceuticals, which is part of Swiss drug manufacturer Novartis International AG.

The settlement resolves a 2011 whistleblower lawsuit accusing Novartis of violating the federal False Claims Act and Anti-Kickback Statute.

The company admitted giving doctors cash, golf and fishing trips, and lavish meals at some of the nation's fanciest restaurants to induce them to prescribe Novartis cardiovascular and diabetes drugs that were reimbursed by federal healthcare programmes, the government said in a release.

Federal authorities alleged that Novartis earned hundreds of millions of dollars in federal reimbursements for selling drugs sold by doctors benefiting from tens of thousands of sham educational events at high-end restaurants and other venues.

 

With the programme, the company paid exorbitant speaker fees to doctors who gave no meaningful presentations while their guests enjoyed fine food and drinks, the government said in court papers.

In settling, Novartis made extensive factual admissions and agreed to strict limitations on any future speaker programs, according to terms of the deal.

William F. Sweeney Jr., head of New York's FBI office, said the company's conduct was “reprehensible and dishonest."

“Not only did Novartis incentivise doctors to host these speaking events, reps bribed the doctors to write more prescriptions of the company's drugs to give Novartis an advantage over competitors within their field," he said.

 

“Greed replaced the responsibility the public expects from those who practice medicine." Some high-prescribing doctors received tens or hundreds of thousands of dollars for their work as Novartis often reimbursed the same group of doctors, colleagues and friends who had dinners together repeatedly, the government said.

Tags: novartis pharmaceutical corp, us government, sham speaker programme, novartis international ag
Location: United States, New York, New York